医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Optibrium Signs Agreement with Zastra Innovations for Distribution in India

2017年02月01日 PM04:42
このエントリーをはてなブックマークに追加


 

CAMBRIDGE, England & BENGALURU, India

Optibrium™, a developer of software for small molecule design and optimisation, announced today that it has appointed Zastra Innovations (Zastra) to be its sole distributor in India for StarDrop™, the company’s flagship product. Zastra will provide researchers in India with the full suite of StarDrop software, combined with local access to expert technical and customer support.

Optibrium selected Zastra based on their reputation for excellence and proven application expertise, as well as the well-established team’s ability to give face-to-face support to customers. Zastra’s CEO, Dr Girinath Pillai, has more than 10 years’ experience in computational chemistry, molecular modelling and QSAR techniques, with a research background from the University of Florida and a Marie Curie Fellowship. By partnering with Zastra, Optibrium has the opportunity to build and extend relationships with the diverse scientific community in India, whilst continuing to provide value to its users globally.

StarDrop is a complete package of fully integrated software for small molecule design, optimisation and data analysis. With a highly visual and user-friendly interface it enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency and productivity of the drug discovery process. Seamlessly connecting with other models, informatics methods and databases, StarDrop provides user-friendly access to resources making project management quicker and simpler.

“We are delighted to announce the partnership with Zastra, a company that shares Optibrium’s values of product and service excellence,” commented Nick Foster, Head of Commercial Operations at Optibrium. “Establishing a dedicated partner in India will ensure our customers in the region have easier, faster access to StarDrop with on-call and on-site support.”

Dr Girinath Pillai added: “Zastra has pursued a long-term vision to provide a portfolio of software and services to leading pharmaceutical, contract research companies, research institutes and universities in India. We are very pleased to be collaborating with Optibrium, one of the leading scientific software partners we work with, as StarDrop is an excellent fit with both our vision and capabilities.”

For further information on Optibrium and StarDrop, please visit www.optibrium.com/stardrop or contact info@optibrium.com.

For further information on Zastra, please visit www.zastrain.com or contact india@optibrium.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170131006529/en/

CONTACT

For Optibrium
Sarah Jeffery
+44 (0)17771 730919
sarah.jeffery@zymecommunications.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Konica Minolta and Innovation Network Corporation of Japan Close Acquisition of Ambry Genetics
  • Median Technologies Appoints Vivian Wang as General Manager, China and Takashi Hayashi as Managing Director, Japan
  • Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs
  • 武田薬品がALK陽性非小細胞肺がんでのALUNBRIGTM(ブリガチニブ)のピボタル第2相ALTA試験の最新データを発表
  • Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products “NMN PURE 3000″ and “NMN PURE 1500″